Avanos Medical, Inc. (AVNS) Tops Q4 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- On Holding sets 2029 financial targets, authorizes $1B share buyback
- Nasdaq reaches record high close, AI stocks rally
- Elmet Group signs tungsten offtake deal with Hemerdon Mine
- Meta bull case increasingly playing out, Mizuho says
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2018 Results, Provides 2019 Outlook
February 26, 2019 7:02 AM ESTALPHARETTA, Ga., Feb. 26, 2019 /PRNewswire/ --Â Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2018 results.
"2018 was a year of continued momentum and achievement, highlighted by strong growth in our Interventional Pain and Chronic Care businesses, the close of the S&IP divestiture and the Game Ready acquisition, and the acceleration of investments for future growth. Additionally, we initiated aggressive action to ensure our cost structure effectively supports our continued growth as a more agile, pure-play medical device company," said Joe Woody, Avanos chief executive... More
